ERFSF
Eurofins Scientific SE
Eurofins Scientific SE historical holders
total: 3
Gardner Russo & Quinn Eurofins Scientific SE transactions over time
- Total transactions:
- 1
- New positions:
- 1
- Held since:
- 2026 Q1
- Held for:
- 1 quarter
- Latest activity:
- 2026 Q1
Thomas Russo has been an institutional investor in Eurofins Scientific SE (ERFSF) since 2026 Q1. According to 2026 Q1 report, Thomas Russo holds 3,096,404 shares with a market value of roughly $223.55M representing 2.63% of their equity portfolio. The fund/company first acquired ERFSF in 2026 Q1, initially purchasing about 3.10M shares.
Does Thomas Russo still hold ERFSF?
Yes, Thomas Russo continues to hold Eurofins Scientific SE (ERFSF). According to their 2026 Q1 report, they maintain a position of 3,096,404 shares valued at approximately $223.55M, representing 2.63% of their equity portfolio.
When did Thomas Russo first invest in ERFSF?
Thomas Russo first invested in Eurofins Scientific SE (ERFSF) in 2026 Q1 at the reported quarter-end price of $72.20 per share, acquiring 3,096,404 shares in their initial purchase.
What is Thomas Russo's average cost basis for ERFSF?
Based on historical transaction data, Thomas Russo's estimated cost basis for Eurofins Scientific SE (ERFSF) is approximately $72.20 per share. This represents their average reported price* across all buy transactions.
Estimated cost basis*
- Weighted AVG buy price:
- $72.20
ERFSF transactions history by Gardner Russo & Quinn
1 result
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2026 Q1
|
2.63%
|
3,096,404
|
$72.20
|
$223,550,621
|
new
|
+2.63%
|
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.